HOME › DRUGS › IRBESARTAN: HYDROCHLOROTHIAZIDE
ACTIVE SUBSTANCE / INN

IRBESARTAN: HYDROCHLOROTHIAZIDE

Brand name(s): IRBESARTAN; HYDROCHLOROTHIAZIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA202414
ACTIVE SUBSTANCE
Irbesartan: Hydrochlorothiazide
REGULATORS
FDA
SPONSORS / MAH
MACLEODS PHARMS LTD
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IRBESARTAN; HYDROCHLOROTHIAZIDEANDA202414MACLEODS PHARMS LTDNone (Tentative Approval)

FULL INTELLIGENCE ON IRBESARTAN: HYDROCHLOROTHIAZIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →